← Back to recalls

Rapid Refill Continuous Injection System, UPN M00566001

Class II
Recalling firm
Boston Scientific Corporation
Reason for recall
Devices contain recalled Medline Namic Angiographic Control Syringe with Rotating Adaptor. There is a risk of syringe loosening or disconnecting from the manifold, resulting in loose connection or complete disconnection. May lead to difficulty connecting syringe, inability to aspirate or inject properly, fluid leakage, or separation of the syringe from the system, potentially requiring device exchange and prolonging the procedure.
Affected products (lot / model / serial)
UDI-DI (GTIN) 08714729285151 Lots 33786611, 33825949, 33826026, 33949916, 33968571, 33968575, 34079981, 34153104, 34153413, 34153415, 34203075, 34203077, 34153411, 34203079, 34203115, 34386605, 34386609, 34386613, 34429656, 34429658, 34595249, 34693559, 34616613, 34616615, 34712433, 34763427, 34763967, 34805723, 34805725, 34805729, 35006995, 35006999, 35056793, 35208946, 35186845, 35208950, 35397314, 35208952, 35305436, 35498030, 35448316, 35498028, 35551523, 35626939, 35574463, 35688118, 35688460, 35828714,35831703, 35848483, 35877768, 35995282, 36049415, 36159194, 36219882, 36294100, 36303614, 36332230, 31177006, 31180206, 31666278, 31329922, 31356107, 31666276, 31798400, 31798133, 31798135, 31798137, 31852246, 32162450, 32208753, 32255526, 32255528, 32496142, 32661870, 32696046, 32696050, 32696052, 32752697, 32773682, 32791475, 32791477, 32820865, 32838612, 32791479, 33119798, 32977346, 32977348, 33030942, 33120320, 33158008, 33158006, 33354311, 33354315, 33354317, 33403248, 33403252, 33696882, 33696884, 33696886, 33696888, 33750883, 33750885, 33750887, 36332232, 36497262, 36159192, 36587704, 36612263, 36739668, 36785215, 36785217, 36814560, 36845486, 36983883, 36983886, 37291592, 37059471, 37417957, 37417959, 37429808, 37456936, 37472523, 37585745, 37627037, 37654892, 37941477, 37974508, 38033021, 38033023, 38124799, 38143635, 38165214, 38182214, 38201123, 37959187, 38353956, 38374833, 38430201, 33968573, 34386611, 32838610, 38205377, 38429054, 34066207, 34429654, 34616611, 34712429, 34763971, 34805727, 35006997, 35448312, 35448314, 35626937, 35688021, 35848481, 35687399, 31616842, 31601573, 31616848, 31616850, 31616846, 32208755, 32455154, 35877766, 36776858, 37037796, 37200706, 37276220, 37291594, 37639238, 38154387, 35305438, 31797614, 33354313, 33696890, 36470789, 37309672, 37396601, 37407323, 37472521, 35056797, 35626933, 33786613, 33825951, 33950422, 34965218, 35056795, 36101020, 36100418, 31356105, 32208759, 32661868, 33030940, 33679650, 37059473, 37041524, 37633157, 37991645, 38137850, 38393609, 33968569, 34703963, 36319481, 33649863, 37019542, 37493275, 34616609, 34386607, 34763969, 34805721, 35942747, 31852244, 32977350, 33354319, 37884043, 38001944, 32752695, 37189280, 37612931, 38703180, 34429700, 33968567, 34017321, 34568306, 34712431, 34873735, 34873737, 34965420, 35007081, 35186843, 35208948, 35397312, 35448310, 35305600, 35626935, 35778515, 35778517, 35778513, 35989120, 36027670, 36049413, 36303612, 36319483, 36312073, 36353951, 36437019, 36517931, 36409546, 36537384, 36622267, 36750117, 36750119, 36994750, 36962014, 37407325, 37456934, 37766480, 37660978, 37764898, 37723376, 37991643, 38856580, 38178214, 38337853, 38326961, 38410111, 38414293, 38576233, 38586789, 38622115, 38633220, 38676778, 38649491, 38680582, 38864691, 38687308, 38876174, 38901702, 31170922, 31601571, 31616844, 31852242, 31852240, 32162448, 32208757, 32696048, 32723872, 32723874, 32838608, 32964550, 32977344, 33119794, 33119796, 33257466, 33334705, 33403250, 33649865, 33933383
Units affected
153,921 (US); 119,274 (OUS)
Distribution pattern
US Nationwide distribution. OUS consignee list pending.
Firm location
Marlborough, MA, United States
Recall type
Voluntary: Firm initiated
How the firm notified customers
Letter
Product type
Devices
Status
Ongoing
Recall number
Z-2725-2026
Recall initiated
June 30, 2026
FDA classification date
July 10, 2026
FDA report date
July 22, 2026
FDA event ID
99336
Last updated on HTM Vibe
July 28, 2026
View on openFDA